FIG 1.
Average anti-S1/S2 IgG antibodies (A) and the neutralization capacity of anti-RBD antibodies (B) in participants with and without COVID-19 prior to vaccination. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.